Basit öğe kaydını göster

The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naive patients with chronic lymphocytic leukemia

dc.contributor.authorONGOREN, Seniz
dc.contributor.authorEsatoglu, Sinem Nihal
dc.contributor.authorKeskin, Dilek
dc.contributor.authorAR, Muhlis Cem
dc.contributor.authorSALİHOĞLU, Ayşe
dc.contributor.authorELVERDİ, Tuğrul
dc.contributor.authorEŞKAZAN, Ahmet Emre
dc.contributor.authorSoysal, Teoman
dc.contributor.authorUZUN, Hafize
dc.contributor.authorAydin, Yildiz
dc.contributor.authorBAŞLAR, Zafer
dc.date.accessioned2021-12-10T11:26:14Z
dc.date.available2021-12-10T11:26:14Z
dc.date.issued2021
dc.identifier.citationEsatoglu S. N. , Keskin D., EŞKAZAN A. E. , ELVERDİ T., SALİHOĞLU A., AR M. C. , ONGOREN S., BAŞLAR Z., Aydin Y., UZUN H., et al., "The prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naive patients with chronic lymphocytic leukemia", TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.1, ss.348-354, 2021
dc.identifier.issn1300-0144
dc.identifier.othervv_1032021
dc.identifier.otherav_7deb36f9-c943-4835-b9a5-8e93882c807a
dc.identifier.urihttp://hdl.handle.net/20.500.12627/171903
dc.identifier.urihttps://doi.org/10.3906/sag-2004-282
dc.description.abstractBackground/aim: A proliferation-inducing ligand (APRIL) has been investigated as a prognostic marker in chronic lymphocytic leukemia (CLL) patients. However, there is no cut-off level for serum APRIL (sAPRIL) levels that predict time to treatment in CLL patients.
dc.language.isoeng
dc.subjectFundamentals and Skills
dc.subjectInternal Medicine
dc.subjectAssessment and Diagnosis
dc.subjectMedicine (miscellaneous)
dc.subjectGeneral Medicine
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectFamily Practice
dc.subjectHealth Sciences
dc.titleThe prognostic value of serum levels of a proliferation-inducing ligand (APRIL) in treatment-naive patients with chronic lymphocytic leukemia
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF MEDICAL SCIENCES
dc.contributor.departmentİstanbul Üniversitesi , Cerrahpaşa Tıp Fakültesi , İç Hastalıkları
dc.identifier.volume51
dc.identifier.issue1
dc.identifier.startpage348
dc.identifier.endpage354
dc.contributor.firstauthorID2604461


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster